ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
19.33
-0.93 (-4.59%)
Mar 31, 2025, 1:41 PM EDT - Market open

ADMA Biologics Market Cap

ADMA Biologics has a market cap or net worth of $4.59 billion as of March 31, 2025. Its market cap has increased by 221.49% in one year.

Market Cap
4.59B
Enterprise Value
4.79B
1-Year Change
221.49%
Ranking
Category
Stock Price
$19.33

Market Cap Chart

Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $4.59B, an increase of 9,049.60%. That is a compound annual growth rate of 48.34%.

History

DateMarket Cap% Change
Mar 28, 20254.81B18.75%
Dec 31, 20244.05B296.92%
Dec 29, 20231.02B33.78%
Dec 30, 2022763.50M176.53%
Dec 31, 2021276.10M49.73%
Dec 31, 2020184.40M-22.29%
Dec 31, 2019237.30M114.17%
Dec 31, 2018110.80M-12.41%
Dec 29, 2017126.50M91.67%
Dec 30, 201666.00M-23.70%
Dec 31, 201586.50M-16.67%
Dec 31, 2014103.80M44.37%
Dec 31, 201371.90M43.23%
View and export this data all the way back to 2013. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings